Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

類似資料

• Improved health status with insulin degludec compared with insulin glargine in people with Type 1 diabetes
  著者:: Home, P D, 等
  出版事項: (2012)
• The Efficacy and Safety of Insulin Degludec Given in Variable Once-Daily Dosing Intervals Compared With Insulin Glargine and Insulin Degludec Dosed at the Same Time Daily: A 26-week, randomized, open-label, parallel-group, treat-to-target trial in individuals with type 2 diabetes
  著者:: Meneghini, Luigi, 等
  出版事項: (2013)
• Insulin degludec improves health-related quality of life (SF-36®) compared with insulin glargine in people with Type 2 diabetes starting on basal insulin: a meta-analysis of phase 3a trials
  著者:: Freemantle, N, 等
  出版事項: (2013)
• Insulin Degludec Versus Insulin Glargine in Insulin-Naive Patients With Type 2 Diabetes: A 1-year, randomized, treat-to-target trial (BEGIN Once Long)
  著者:: Zinman, Bernard, 等
  出版事項: (2012)
• Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials
  著者:: Ratner, R E, 等
  出版事項: (2013)